ovalbumin and Parkinson-Disease

ovalbumin has been researched along with Parkinson-Disease* in 2 studies

Trials

1 trial(s) available for ovalbumin and Parkinson-Disease

ArticleYear
    The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa, 2021, Volume: 27

    Childhood trauma may contribute to poorer premorbid social and academic adjustment which may be a risk factor for schizophrenia.. We explored the relationship between premorbid adjustment and childhood trauma, timing of childhood trauma's moderating role as well as the association of clinical and treatment-related confounders with premorbid adjustment.. Type of childhood trauma was assessed with the Childhood Trauma Questionnaire, short-form and premorbid adjustment using the Premorbid Adjustment Scale. Timing of childhood trauma was assessed using the Life Events Checklist and life events timeline. Linear regression analyses were used to assess the moderating effect of timing of childhood trauma. Clinical and treatment-related confounders were entered into sequential hierarchical regression models to identify independent predictors of premorbid adjustment across key life stages.. Childhood physical neglect was associated with poorer premorbid academic functioning during childhood and early adolescence, and poorer premorbid social functioning during early and late adolescence. By hierarchical regression modelling (. In patients with FES, childhood physical neglect may contribute to poorer premorbid social functioning during early adolescence. This may provide us with an opportunity to identify and treat at-risk individuals earlier.. Utilization of pharmacy services including telehealth, may allow clinical pharmacists to collaboratively provide remote services without jeopardizing patient outcomes. Larger studies are needed to confirm these findings, and display the long-term impact and satisfaction of these services.. Treatment of Staphylococcus aureus IE in IDUs on methadone treatment requires the use of high daptomycin daily doses in order to achieve satisfactory pharmacodynamic parameters. Close monitoring of the daptomycin plasma concentration is suggested.

    Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Area Under Curve; Atherosclerosis; B7-H1 Antigen; Bronchoalveolar Lavage Fluid; C-Reactive Protein; Calgranulin B; Cause of Death; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Combined Modality Therapy; Comorbidity; Cost-Benefit Analysis; COVID-19; COVID-19 Vaccines; CRISPR-Cas Systems; Daptomycin; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Neoplasm; Drug Therapy, Combination; Endocarditis, Bacterial; Enzyme Inhibitors; Extracellular Matrix; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; Gene Targeting; Glioblastoma; Half-Life; Health Status; Heterocyclic Compounds, 1-Ring; Hospital Mortality; Humans; Interleukin-6; L-Lactate Dehydrogenase; Lung; Lung Diseases, Interstitial; Male; Matrix Metalloproteinase 13; Methadone; Mice; Mice, Inbred C57BL; Mice, Knockout; Microbial Sensitivity Tests; Microglia; Middle Aged; Neuroendocrine Tumors; Octreotide; Opiate Substitution Treatment; Ovalbumin; Oxygen; Oxygen Inhalation Therapy; p38 Mitogen-Activated Protein Kinases; Parkinson Disease; Partial Pressure; Phenotype; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Quality of Life; Radiotherapy Dosage; Radiotherapy, Conformal; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus; Staphylococcal Infections; Staphylococcus aureus; Surveys and Questionnaires; Survival Rate; Sweden; Temozolomide; Tissue Distribution; Tomography, X-Ray Computed; Treatment Outcome; Tumor-Associated Macrophages; Young Adult

2021

Other Studies

1 other study(ies) available for ovalbumin and Parkinson-Disease

ArticleYear
Antibodies from patients with Parkinson's disease react with protein modified by dopamine oxidation.
    Journal of neuroscience research, 1998, Sep-01, Volume: 53, Issue:5

    To determine whether specific antibodies are present in PD, we used an enzyme-linked immunosorbant assay (ELISA) that identifies increased immunoglobulin (IgG) levels towards a synthetic substrate prepared by incubating ovalbumin with dopamine and copper sulfate. Altered absorption spectrum and specific chemical detection demonstrated quinone modification of the ovalbumin. This modified protein was demonstrated to react with serial dilutions of PD sera. A threshold dilution of 1:500 was subsequently used to screen sera from patients with PD (n = 21), amyotrophic lateral sclerosis (n = 7), Alzheimer's disease (n = 7) and other neurological disease controls (n = 7). The assay produced a positive result in 7/21 PD patients and 0/21 disease controls (P < 0.02, Kruskal-Wallis test). Further testing of sera from untreated PD patients (n = 6) identified one positive sample. Thus, a subset of Parkinson's disease (PD) patients has immunoglobulin (IgG) to ovalbumin modified by dopamine oxidation. The presence of antibody reactivity to quinone-modified proteins could contribute to or amplify the inflammatory response in PD.

    Topics: Aged; Chromatography, High Pressure Liquid; Copper Sulfate; Cross-Linking Reagents; Dopamine; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immune Sera; Immunoglobulin G; Male; Middle Aged; Ovalbumin; Oxidation-Reduction; Parkinson Disease; Quinones; Serologic Tests; Spectrophotometry

1998